Gilsenan AW, Midkiff KD, Harris DH. Opportunities for improving the use of cancer registry data in drug safety studies: factors influencing interview response rate. Presented at the North American Association of Central Cancer Registries Annual Conference; 2011.
Blum JL, Kohles J, McKenna E, Scotto N, Hu S, Odom D, Kaye JA, Glück S. Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials. Breast Cancer Res Treat. 2011 Jan 1;125(2):431-9.
Nastoupil L, Sinha R, Byrtek M, Taylor M, Cerhan JR, Friedberg J, Ziemiecki RM. A comparison of the effectiveness of first-line chemoimmunotherapy regimens for follicular lymphoma (FL) used in the United States. Presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Jan; 118(21):97. doi: 10.1182/blood.V118.21.97.97
Midkiff KD, Gilsenan AW, Harris DH, Wu Y, Masica D, Andrews EB. Exposure to possible osteosarcoma risk factors in a US postmarketing osteosarcoma surveillance study. Poster presented at the Scandinavian Sarcoma Group Annual Meeting; 2011.
Hessol N, Pipkin S, Scheer S, Okeigwe I, Schwarcz S, Harris DH. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma survival time. Poster presented at the 18th Annual Conference on Retroviruses and Opportunistic Infections; 2011.
Dine JL, Austin MK, Armer JM. Nursing education on lymphedema self-management and self-monitoring in a South African oncology clinic. J Cult Divers. 2011;18(4):126-8.
Mauskopf JA. A method for estimating the magnitude and timing of excess cancer risks from less-than-lifetime exposures to contaminated well water. J Hazard Mater. 1990 Jan 1;23(3):263-73.